Innate immunity in cystic fibrosis lung disease.

Innate immunity in cystic fibrosis lung disease.

Chronic lung disease determines the morbidity and mortality of cystic fibrosis (CF) patients. The pulmonary immune response in CF is characterized by an early and non-resolving activation of the innate immune system, which is dysregulated at several levels. Here we provide a comprehensive overview o...

Full description

Bibliographic Details
Main Authors:	Hartl, D, Gaggar, A, Bruscia, E, Hector, A, Marcos, V, Jung, A, Greene, C, McElvaney, G, Mall, M, Döring, G
Format:	Journal article
Language:	English
Published:	2012

Similar Items

Targeting IgG Autoantibodies for Improved Cytotoxicity of Bactericidal Permeability Increasing Protein in Cystic Fibrosis
by: Karen McQuillan, et al.
Published: (2020-07-01)

Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
by: Bergin DA, et al.
Published: (2013-01-01)

Neutrophil Membrane Cholesterol Content is a Key Factor in Cystic Fibrosis Lung Disease
by: Michelle M. White, et al.
Published: (2017-09-01)

Editorial: Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
by: Carla Maria Pedrosa Ribeiro, et al.
Published: (2021-11-01)

Chitinase activation in patients with fungus-associated cystic fibrosis lung disease
by: Hector, Andreas, et al.
Published: (2017)

miR-224-5p and miR-545-5p Levels Relate to Exacerbations and Lung Function in a Pilot Study of X-Linked MicroRNA Expression in Cystic Fibrosis Monocytes
by: Paul J. McKiernan, et al.
Published: (2021-11-01)

Impaired Airway Epithelial Barrier Integrity in Response to Stenotrophomonas maltophilia Proteases, Novel Insights Using Cystic Fibrosis Bronchial Epithelial Cell Secretomics
by: Kevin Molloy, et al.
Published: (2020-02-01)

Altered Degranulation and pH of Neutrophil Phagosomes Impacts Antimicrobial Efficiency in Cystic Fibrosis
by: Elaine Hayes, et al.
Published: (2020-12-01)

Innate immunity mediated by TLR5 as a novel antiinflammatory target for cystic fibrosis lung disease.
by: Blohmke, C, et al.
Published: (2008)

Quantification of Phenotypic Variability of Lung Disease in Children with Cystic Fibrosis
by: Mirjam Stahl, et al.
Published: (2021-05-01)

Cystic fibrosis disease severity correlates with plasma levels of desmosine and isodesmosine, biomarkers of elastin degradation
by: Shuren Ma, et al.
Published: (2019-06-01)

MicroRNAs in inflammatory lung disease - master regulators or target practice?
by: Greene Catherine M, et al.
Published: (2010-10-01)

Emerging Concepts in Defective Macrophage Phagocytosis in Cystic Fibrosis
by: Devi Jaganathan, et al.
Published: (2022-07-01)

Neutrophil extracellular traps and the dysfunctional innate immune response of cystic fibrosis lung disease: a review
by: Sheonagh M. Law, et al.
Published: (2017-12-01)

Innate Immunity of the Lung
by: Catherine M. Greene, et al.
Published: (2019-12-01)

Role of innate immunity and systemic inflammation in cystic fibrosis disease progression
by: Anand Kumar Purushothaman, et al.
Published: (2023-07-01)

Targeting the Heme Oxygenase 1/Carbon Monoxide Pathway to Resolve Lung Hyper-Inflammation and Restore a Regulated Immune Response in Cystic Fibrosis
by: Caterina Di Pietro, et al.
Published: (2020-07-01)

Antimicrobial proteins and polypeptides in pulmonary innate defence
by: Taggart Clifford C, et al.
Published: (2006-02-01)

Alterations in innate immune responses of patients with chronic rhinosinusitis related to cystic fibrosis.
by: Gustavo L Rezende, et al.
Published: (2022-01-01)

Differential epithelial expression of the putative innate immune molecule SPLUNC1 in Cystic Fibrosis
by: Wallace William A, et al.
Published: (2007-11-01)

Unconventional T Cell Immunity in the Lungs of Young Children with Cystic Fibrosis
by: Rebecca McElroy, et al.
Published: (2022-05-01)

Immunomodulation in Cystic Fibrosis: Why and How?
by: Vincent D. Giacalone, et al.
Published: (2020-05-01)

Inhibition of histone-deacetylase activity rescues inflammatory cystic fibrosis lung disease by modulating innate and adaptive immune responses
by: Manish Bodas, et al.
Published: (2018-01-01)

Diagnostic agreement among experts assessing adults presenting with possible cystic fibrosis: need for improvement and implications for patient care
by: Alessandro N. Franciosi, et al.
Published: (2022-12-01)

Diagnosing α1-antitrypsin deficiency: how to improve the current algorithm
by: Noel G. McElvaney
Published: (2015-03-01)

Lung immunoglobulin A immunity dysregulation in cystic fibrosis
by: Amandine M. Collin, et al.
Published: (2020-10-01)

Oxidant lung injury in cystic fibrosis
by: Chmiel James, et al.
Published: (2000-11-01)

Biofilm-Induced Type 2 Innate Immunity in a Cystic Fibrosis Model of Pseudomonas aeruginosa
by: Kenny Bielen, et al.
Published: (2017-06-01)

The Basophil Surface Marker CD203c Identifies Aspergillus Sensitization in 2 Cystic Fibrosis
by: Mirković, Bojana, et al.
Published: (2016)

High-intensity interval training accelerates oxygen uptake kinetics and improves exercise tolerance for individuals with cystic fibrosis
by: Ronen Reuveny, et al.
Published: (2020-04-01)

Blood basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis in cystic fibrosis
by: Gernez, Yael, et al.
Published: (2017)

A pathologic two‐way street: how innate immunity impacts lung fibrosis and fibrosis impacts lung immunity
by: Helen I Warheit‐Niemi, et al.
Published: (2019-01-01)

Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection.
by: Cristina Cigana, et al.
Published: (2009-12-01)

Lung Microbiome in Cystic Fibrosis
by: Filippo Scialo, et al.
Published: (2021-01-01)

A Volatile and Dynamic Longitudinal Microbiome Is Associated With Less Reduction in Lung Function in Adolescents With Cystic Fibrosis
by: Marisa I. Metzger, et al.
Published: (2021-12-01)

Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in MicrobiotaSummary
by: Romina Fiorotto, et al.
Published: (2019-01-01)

TRACK-CF prospective cohort study: Understanding early cystic fibrosis lung disease
by: Eva Steinke, et al.
Published: (2023-01-01)

Osteoporose em fibrose cística Osteoporosis in cystic fibrosis
by: Gerd Döring, et al.
Published: (2008-02-01)

Anti-Inflammatory Influences of Cystic Fibrosis Transmembrane Conductance Regulator Drugs on Lung Inflammation in Cystic Fibrosis
by: Kiera H. Harwood, et al.
Published: (2021-07-01)

Potential of Intestinal Current Measurement for Personalized Treatment of Patients with Cystic Fibrosis
by: Simon Y. Graeber, et al.
Published: (2021-05-01)